INTRODUCTION
Obesity is a major health problem worldwide and has reached an epidemic in the Western society and in India also & is a major risk factor due to associated comorbidities with significant morbidity and mortality.. It has been shown in longitudinal studies that non-surgical treatment of morbid obesity does not lead to any meaningful weight loss. 90-95% of people who lose weight regain all or most of their lost weight thus; surgery is the only effective modality for significant and sustained weight loss & also helps in resolution of associated comorbidities like diabetes, hypertension, sleep apnea and osteoarthritis. Laparoscopic bariatric surgery is a unique field, This proven surgical approach provide improvement in quality of life and the quick recovery Weight loss operations can be divided into restrictive procedures and malabsorptive procedures. Malabsorptive procedures reduce the absorption of calories, proteins and other nutrients. In contrast, restrictive operations decrease food intake and promote a feeling of early fullness (satiety) after meals. Some operations are a combination of both: Staged Procedures v/s single procedure Staged Procedures. This approach involves performing a less invasive procedure that reduces weight to a safer level (which in itself is not effective enough on its own) and improves overall medical condition first; then a more complex, definitive procedure is performed once the operative risks of the patient decrease significantly due to the initial weight loss. These less invasive steps have included the laparoscopic "sleeve gastrectomy" the gastric balloon and the adjustable band as an interim step before. Laparoscopic RYGBP or DS or Biliopancreatic Diversion is performed in selected patients less invasive procedures adequately control problem.
Aim and objectives
Aim and objectives of the study was: 
Operative procedure
During the sleeve gastrectomy, about 75 percent of the stomach is removed leaving a narrow gastric tube or "sleeve". No intestines are removed or bypassed during the sleeve gastrectomy. 75 percent of patients will have significant improvement or resolution of major obesityrelated co-morbidities such as diabetes, hypertension, sleep apnea and hyperlipidaemia following sleeve gastrectomy. However, as these procedures are potentially much safer than other operations, they may have a significant role in the future. 
Gastric bypass
Dr. Mason and Ito initially developed this procedure in the 1960s. Over several decades, the gastric bypass has been modified into its current form, using a Roux-en-Y limb of intestine (RYGBP). The RYGBP is the most commonly performed operation for weight loss initially the operation was performed as a loop bypass with a much larger stomach. Because of bile reflux that occurred with the loop configuration, the operation is now performed as a "Roux-en-Y" with a limb of intestine connected to a very small stomach pouch which prevents the bile from entering the upper part of the stomach and esophagus. The remaining stomach and first segment of small intestine are bypassed. The RYGBP has been proven in numerous studies to result in durable weight loss and an improvement in weight-related medical illnesses. Half of the weight loss often occurs during the first six months after surgery; weight loss usually peaks at 18-24 months. The obesity-related comorbidities that may be improved or cured with the RYGBP include diabetes mellitus of the adult onset type (so-called insulin resistant), hypertension, high cholesterol, arthritis,. RYGBP has resulted in marked improvements in quality of life.
RESULTS
In our study we took 145 pt of obesity operated during may 2011-april 2012 followed them for a period of 1-2 year. Following results noted.
Age variation & Sex ratio
Age variation & sex ratio of pt. was from 17-69 years with maximum number between 41-60(table no.1) & male were 69 (48%) and female were 76 (52%) ( Figure  2 ). 
Weight reduction
Weight reduction shift from range 92-210 kg to 55-140 kg. Average weight reduction in majority was approx. 45 kg. maximum weight range was in between 61-80 Almost equal result in both type of surgeries.
Weight distribution curve with maximum number of patients ranges between 100-140 kg.
Post-operative weight reduction with maximum range in between 61-80 kg. In diabetic patients, post-operative reduction in hba1c (<6 normal value). 40% were <6 & 35% patients were near normal range (6.1-6.5).
Statistical analysis
In group1 & group 2 the chi sq value (22.8) is highly sensitive (HS) as the calculated value is more than the tabulated value with control of diabetes in both groups.
Here also it is found that the chi sq value calculated is found to be more than the tabulated chi sq value at 1 DOF showing that there is highly significant association between the pre-operative & post-operative weight.
Here in all group the calculated chi sq value is found to be more than tabulated value. Showing that there is highly significant difference in the pre op & post op BMI after surgery.
DISCUSSION
In our study of 145 patients we found out that there is definitive weight loss with mean weight loss of around of 40-60 kg with weight reduction shift from range 92-210 kg to 55-140 kg & BMI reduction shift from 29-77 to 21.1 to 46.6. Other study done which also suggest weight loss & BMI reduction are as follows. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In all diabetes pt, post-operative reduction in HbA1c (<6 normal value).In 40% patients were <6 & 35% patients were near normal range (6.1-6.5). There is good glycemic control after bariatric surgery. Other studies which also has glycemic control are as follows. 1, 2, 4, 6, [8] [9] [10] 12, 14, [16] [17] [18] [19] 21, 22 Type of surgery in DM in 65% SG was done & in 35%. RYGB was done with similar result in glycemic control in both surgeries. Other studies which also has similar results were as follows. 16, 17, 20 Type of surgery in DM in 65% SG was done & in 35%. RYGB was done with almost similar result in glycemic control in both surgeries. 
